#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Choroidal dystrophy Dent's disease Ewing's sarcoma recurrent Thrombocytosis Microscopic polyangiitis Chondrosarcoma metastatic Craniopharyngioma Anaplastic large cell lymphoma T- and null-cell types Transferrin decreased Familial amyotrophic lateral sclerosis Vascular calcification Palmoplantar pustulosis Oesophageal adenocarcinoma stage III Meningitis meningococcal Meningococcal immunisation More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Life with Disease Cytokine release syndrome – Life with Disease Splenic marginal zone lymphoma – Life with Disease Antithrombin III deficiency – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Proteus syndrome – Basic Information Glomerulonephritis membranous Alveolar rhabdomyosarcoma – Life with Disease Malignant fibrous histiocytoma – Diagnostics Chondrosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Desvenlafaxine Benzoate Bbp-398 Roxithromycin Pentixafor Oleclumab Sotalol Selatogrel Tamsulosin Hydrochloride Ixazomib Citrate Resiquimod Sulfate Belzutifan FOSFOMYCIN CALCIUM Octreotide Hydrochloride SODIUM SELENITE PENTAHYDRATE Utreglutide Zinc Acexamate AMO959 Avutometinib Cenerimod Clemastine Fumarate More therapies…

    Learn about Your Condition

    Erythema multiforme Low cardiac output syndrome Autism spectrum disorder Alcohol use disorder Neck pain Embolism venous Cortisol abnormal Leiomyosarcoma metastatic Eye pain Procedural hypotension Dyskinesia Vulvovaginal discomfort T-cell type acute leukaemia Oedema peripheral Biliary neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Gene Therapy with AAV9.LAMP2B for Male Patients with Danon Disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 9 Vector Containing The Human Lamp2 Isoform B Transgene
    • Methylprednisolone Sodium Succinate
    • Sirolimus
    Germany Italy

  • Study on Axial Spondyloarthritis Treatment Using Technetium-Labeled Certolizumab Pegol for Patients with Axial Spondyloarthritis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Technetium (99Mtc) Certolizumab Pegol
    Belgium

  • Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Regadenoson
    • Syn2
    • Adenosine
    Poland

  • Study on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Denmark France Germany +5

  • Study of Gedatolisib and Darolutamide Combination Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Gedatolisib
    • Darolutamide
    • Dexamethasone
    France Spain

  • Study on the Safety and Feasibility of Bevacizumab-800CW Imaging for Patients with Barrett’s Esophagus, Colon Cancer, or Gastrointestinal Dysplasia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Barrett’s oesophagus
    • Colon cancer
    Investigated Drugs:
    • Bevacizumab
    The Netherlands
Previous Page
1 … 566 567 568 569 570 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!